Nosocomial Vaccine Corporation Announces Presentation on Multivalent Vaccine for Gram-Negative Pathogens, including Multiple Antibiotic-Resistant Strains at World Vaccine Conference
Dr. Monika Weber - CEO of Fluid Screen - Disrupting traditional Petri Dish Methods for Bacterial Testing
Doctors say 'superblood' may work against deadly malignancies
Cedilla Therapeutics Launches with $56.2 Million
Inside a tiny Cambridge biotech’s plot to make cancer self-destruct
Third Rock Ventures Launches Casma Therapeutics with $58.5 Million Investment to Harness the Cellular Process of Autophagy to Develop Breakthrough Therapies
Third Rock Ventures Launches Rheos Medicines with $60 Million in Series A Funding to Harness Immunometabolism to Develop Precision Medicines for Immune-mediated Diseases
Servier backs American startup’s research project at LabCentral
HiFiBiO Therapeutics Secures $37.5 Million Series B Financing to Accelerate Pipeline of Novel Antibody Drugs to Treat Cancer and Autoimmune Disorders
